Loading…
CapsoVision, Inc. is projected to rise to $6.93 by 2027, a +5% move from its current price of $6.58. CV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $6.36 | $6.58 | $6.81 | +0.02% |
| Aug 4 | $6.26 | $6.58 | $6.92 | +0.03% |
| Aug 5 | $6.20 | $6.58 | $6.99 | +0.05% |
| Aug 6 | $6.14 | $6.58 | $7.06 | +0.06% |
| Aug 7 | $6.09 | $6.59 | $7.12 | +0.08% |
| Aug 8 | $6.05 | $6.59 | $7.17 | +0.10% |
| Aug 9 | $6.01 | $6.59 | $7.23 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.01 | $6.59 | $7.23 | +0.11% |
| Week 2 | $5.79 | $6.59 | $7.52 | +0.22% |
| Week 3 | $5.63 | $6.60 | $7.75 | +0.34% |
| Week 4 | $5.49 | $6.61 | $7.95 | +0.45% |
| Week 5 | $5.38 | $6.62 | $8.14 | +0.56% |
| Week 6 | $5.28 | $6.62 | $8.31 | +0.68% |
| Week 7 | $5.19 | $6.63 | $8.47 | +0.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CapsoVision, Inc. is a medical technology company that manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.
Its product lineup includes CapsoCam Plus for visualization of the small bowel mucosa in adults and children aged 2 years and above; CapsoCam Colon for visualization of the colon and detection and measurement of polyps; and CapsoColon 3D for large intestines. It also provides CapsoCloud, a cloud-based software-as-a-service ecosystem; CapsoView, a data access reading device; CapsoAccess, CapsoRetrieve, and capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals and sells its products to distributor customers who resell them.
The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.
CapsoVision, Inc. trades under the symbol CV. The current price is $6.71 with a market capitalization of $335.26M, and it holds a rank of 3262 among listed assets.
The near-term outlook reflects a neutral stance for 2026, with an average price forecast of $6.71 and a min of $4.64 and max of $10.01; sentiment for 2026 is Neutral. The 30-day technical picture shows bullish sentiment overall, with a current price near its moving averages and defined support and resistance levels.
Beyond 2026, the forecast depicts a bullish growth trajectory, with 2027 average $8.17 and 2028 average $10.38, rising to 2029 average $14.43 and 2030 average $18.80. The forecast continues to show upside into the 2040s and 2050s, with 2040 average $53.59 and max $121.72, and 2050 average $161.78 with a max of $372.10. These years carry rising ROI figures, from 21.8% in 2027 to 180.2% in 2030, 698.7% in 2040, and 2311.1% in 2050.
A major floor 28.6% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
The nearest ceiling, 15.2% above — a clean break opens room to run.
A major ceiling 32.1% above — clearing it would confirm fresh momentum.
Key CV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.63 | Sell | $6.63 | Sell |
| MA 10 | $6.69 | Sell | $6.62 | Sell |
| MA 20 | $6.45 | Buy | $6.63 | Sell |
| MA 50 | $6.76 | Sell | $6.68 | Sell |
| MA 100 | $6.67 | Sell | $6.61 | Sell |
| MA 200 | $6.61 | Sell | $6.27 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.50 | Neutral |
| Stoch RSI (14) | 28.73 | Neutral |
| CCI (20) | 30.17 | Neutral |
| Williams %R (14) | -63.77 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 3.95 | Buy |
| Bollinger %B (20,2) | 0.59 | Neutral |
| Stochastic %K (14) | 36.23 | Neutral |
| TRIX (15) | -0.13 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 40.53 | Neutral |
| Momentum (10) | -0.13 | Sell |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 6.62 | Sell |
| ADX (14) | 7.53 | Neutral |
| ATR (14) | 0.18 | Info |
Technically, the 30-day picture shows a bullish tilt in sentiment, with RSI(14) at 50. The stock is positioned between its SMA50 of $6.81 and SMA200 of $6.51, suggesting a slight overshoot above the longer-term average. A clear support level is listed at $5.67 and a resistance level at $7.58, with a 30-day price range from $5.00 to $9.00.
Annualized volatility is high at 90%, indicating sizable near-term swings.
Overall, the combination of bullish sentiment and a neutral RSI reading paints a picture of potential upside if price moves toward the resistance while respecting the near-term support. Traders may watch for a move above $7.58 to confirm upside momentum, or a break below $5.67 to re-evaluate near-term risk.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.64 | $6.58 | $9.05 | 0% | Neutral | |
| $5.22 | $6.93 | $9.88 | +5% | Neutral | |
| $5.71 | $7.95 | $11.99 | +21% | Bullish | |
| $6.47 | $9.39 | $14.77 | +43% | Bullish | |
| $7.59 | $11.42 | $18.62 | +74% | Bullish | |
| $8.86 | $13.79 | $23.18 | +110% | Bullish | |
| $8.14 | $13.09 | $22.61 | +99% | Bullish | |
| $7.91 | $13.11 | $23.20 | +99% | Bullish | |
| $8.90 | $15.19 | $27.48 | +131% | Bullish | |
| $8.76 | $15.38 | $28.40 | +134% | Bullish | |
| $11.81 | $23.72 | $47.66 | +260% | Bullish | |
| $25.42 | $56.50 | $128.02 | +759% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.64 | $6.58 | $7.99 | +0.00% |
| September 2026 | $5.31 | $6.40 | $8.00 | -2.77% |
| October 2026 | $5.48 | $6.68 | $8.49 | +4.37% |
| November 2026 | $5.69 | $6.99 | $9.01 | +4.67% |
| December 2026 | $5.60 | $6.94 | $9.05 | -0.73% |
Click any year to see its month-by-month CV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CV to range from $4.64 to $9.05 through 2026. The $6.58 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CV price prediction for 2027 points to an average of $6.93 (low $5.22, high $9.88) — a potential gain of +5% on today's $6.58. A consolidation phase looks the most probable path here.
In 2028, CV is projected to trade between $5.71 and $11.99, averaging $7.95 — a potential gain of +21% from today's $6.58. That is up +15% on the projected 2027 average. Momentum favours further upside here.
CapsoVision, Inc.'s 2029 outlook centres on $9.39, within a $6.47 to $14.77 range. That is up +18% on the projected 2028 average. That marks a +43% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CV could reach as high as $18.62, with a base case around $11.42 and support toward $7.59 — roughly +74% from $6.58. Momentum favours further upside here.
Expect CV to range from $8.86 to $23.18 through 2031. The $13.79 average target implies a +110% move from current prices. That is up +21% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CV price prediction for 2032 points to an average of $13.09 (low $8.14, high $22.61) — a potential gain of +99% on today's $6.58. Momentum favours further upside here.
In 2033, CV is projected to trade between $7.91 and $23.20, averaging $13.11 — a potential gain of +99% from today's $6.58. That is up 0% on the projected 2032 average. Buyers look set to stay in control over this stretch.
CapsoVision, Inc.'s 2034 outlook centres on $15.19, within a $8.90 to $27.48 range. That is up +16% on the projected 2033 average. That marks a +131% change versus current levels. Momentum favours further upside here.
By 2035, CV could reach as high as $28.40, with a base case around $15.38 and support toward $8.76 — roughly +134% from $6.58. Buyers look set to stay in control over this stretch.
Expect CV to range from $11.81 to $47.66 through 2040. The $23.72 average target implies a +260% move from current prices. That is up +54% on the projected 2035 average. Momentum favours further upside here.
The CV price prediction for 2050 points to an average of $56.50 (low $25.42, high $128.02) — a potential gain of +759% on today's $6.58. Buyers look set to stay in control over this stretch.
Investing $1,000 in CV today (≈ 151.975684 CV) could be worth
$8,586.36
+$7,586.36 (+759%) by 2050 · US Dollar
Based on the average projected CV price of $56.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVwould be worth at today's price.
$1,000 invested in CV on Jul 31, 2025 (≈ 258.732212 CV) would be worth
$1,702.46
+$702.46 (+70.2%) today · 1.70× · US Dollar
Based on a CV entry price of $3.87 vs. today's $6.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.49 | $1,013.87 | +1.4% |
| 1 month ago | $7.37 | $892.81 | -10.7% |
| 3 months ago | $7.5 | $877.33 | -12.3% |
| 6 months ago | $5.47 | $1,202.93 | +20.3% |
| 1 year ago | $3.87 | $1,702.46 | +70.2% |
| All time (1.1y) ago | $3.5 | $1,880 | +88.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CV forecast.
Our base-case forecast reaches $13.00 around 2031.
Implied market cap at $13.00: $649.53M
The multi-year forecast shows a strong bullish trajectory, with 2030 average price of $18.80 and an ROI of 180.2%, and a 2040 average of $53.59 with an ROI of 698.7%. The upside continues into 2050, with an average of $161.78 and a max of $372.10, yielding an ROI of 2311.1% and a bullish sentiment. Earlier years also show rising averages and positive ROIs, such as 2027 average $8.17 (ROI 21.8%), 2028 average $10.38 (ROI 54.7%), and 2029 average $14.43 (ROI 115%).
These figures illustrate a strong long-term upside potential, but as with any forecast, they are estimates and not guarantees. The outlook remains subject to market conditions and company-specific developments that could influence actual results.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $18.80, with a min of $11.28, a max of $33.40, and an ROI of 180.2%, with bullish sentiment.
The 2027–2050 forecast series suggests a bullish trajectory with rising averages and ROIs (e.g., 2027 avg $8.17, 2028 avg $10.38, 2029 avg $14.43, 2030 avg $18.80, up to 2050 avg $161.78 and max $372.10). The 2026 forecast is neutral at $6.71. These are estimates and not guarantees.
Yes. The forecast shows a 2040 max of $121.72 and a 2050 max of $372.10, indicating that $100 could be reached in the forecast horizon, particularly by 2040 or later.
Current price is $6.71 and market capitalization is $335.26M.
The long-term outlook shows a rising trajectory with 2050 average price of $161.78 and a max of $372.10, supported by bullish sentiment and substantial ROIs up to 2311.1% by 2050; note these are forecasts and not guarantees.
CapsoVision, Inc. Community Discussion
0Share your CapsoVision, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.